Post sponsored by NewzEngine.com

MIL OSI Translation. Region: Russian Federation –

26 August 2021, 09:06

Share this

Photo by E. Samarin. Mos.ru

Starting next year, patients with cancer of the bladder, ovaries, stomach, and malignant tumors of the head and neck will begin receiving drugs of the latest generation.

Despite the pandemic, the city will continue to improve the quality of medical care, including the cancer program. Wrote about it Sergei Sobyanin on his blog.

“Over the past two years, we have introduced a new Moscow standard of oncological care and ensured the continuity of patient management at all stages – from diagnosis to treatment and subsequent rehabilitation,” said the Moscow Mayor.

One of the main issues is the provision of drugs for cancer patients. Modern targeted, immune and hormonal drugs cope even with those types of tumors that were previously considered almost incurable. According to Sergei Sobyanin, the city is doing everything to make the latest medicines available to all Muscovites in need.

In addition, it is extremely important for doctors to choose the right treatment tactics – this requires complex tests. Six modern centralized pathomorphological laboratories equipped with the latest technology have been deployed in the capital’s clinics. Last year, they conducted 400 thousand morphological and about 100 thousand immunohistochemical and molecular genetic studies of neoplasms. Several years ago, the number of such studies was estimated at several hundred per year.

In 2019, Moscow was the first in Russia to expand the standards of drug therapy for six cancer sites (melanoma, breast, prostate, kidney, rectal and lung cancer). These neoplasms account for about 80 percent of cancer diagnoses in the capital. For two years, almost 55 thousand patients received more than 800 thousand packages of drugs.

Sergei Sobyanin said that starting from 2022, patients with four more types of cancer – bladder, ovarian, stomach, and malignant tumors of the head and neck – will receive the latest generation drugs.

“Thus, the Moscow program of modern drug therapy will cover 90 percent of oncological diseases,” the Moscow Mayor emphasized.

He added that the cost of treating a patient with oncology can reach 500 thousand rubles a month. In 2019, the city has approximately doubled its spending on medicines – up to 33 billion rubles a year. This amount will rise again in 2022.

In addition, leading experts in oncology are working to create a mechanism for assessing the effectiveness of new anticancer drugs. The best of them will be quickly included in the standards of treatment of cancer patients.

EDITOR’S NOTE: This article is a translation. Apologies should the grammar and or sentence structure not be perfect.

MIL OSI Russia News